Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrilla- tion. N Engl J Med. 2011;365:981 992. doi: 10.1056/NEJMoa1107039. 305. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemor- rhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998;280:1930 1935. 306. Thompson BB, B jot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K, Giroud M, Greenberg SM, Hallevi H, Hemphill JC 3rd, Heuschmann P, Juvela S, Kimura K, Myint PK, Nagakane Y, Naritomi H, Passero S, Rodr guez-Y ez MR, Roquer J, Rosand J, Rost NS, Saloheimo P, SalomaaV, Sivenius J, Sorimachi T, Togha M, Toyoda K, Turaj W,Vemmos KN, Wolfe CD, Woo D, Smith EE. Prior antiplatelet ther- apy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333 1342. doi: 10.1212/WNL.0b013e3181f735e5. 307. ViswanathanA, Rakich SM, Engel C, Snider R, Rosand J, Greenberg SM, Smith EE. Antiplatelet use after intracerebral hemorrhage. Neurology. 2006;66:206 209. doi: 10.1212/01.wnl.0000194267.09060.77. 308. Goldstein LB, Amarenco P, Szarek M, Callahan A 3rd, Hennerici M, Sillesen H, Zivin JA, Welch KM; SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2008;70(24 Pt 2):2364 2370. doi: 10.1212/01. wnl.0000296277.63350.77. 309. Hackam DG,Austin PC, HuangA, Juurlink DN, Mamdani MM, Paterson JM, Hachinski V, Li P, Kapral MK. Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol. 2012;69:39 45. doi: 10.1001/ archneurol.2011.228. 310. McKinney JS, Kostis WJ. 